MktsMarkets

Vanda Pharmaceuticals Inc.
NASDAQ: VNDAKey statistics
VNDA News
Stories mentioning VNDA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 51,718 | 57,216 | 56,258 | 52,590 | 50,041 | 53,185 | 47,651 | 50,474 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 28,435 | 29,006 | 22,563 | 21,990 | 35,712 | 19,840 | 16,776 | 16,661 |
| Sales General & Admin | 68,361 | 62,978 | 60,273 | 64,616 | 50,084 | 39,282 | 37,573 | 39,474 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (50,224) | (40,353) | (31,284) | (38,503) | (41,028) | (10,279) | (11,000) | (10,146) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | (48,424) | (38,002) | (28,390) | (34,887) | (37,368) | (6,497) | (6,244) | (5,516) |
| Tax Provision | 143.00 | 103,185 | (5,804) | (7,680) | (7,874) | (1,585) | (920.00) | (998.00) |
| Net Income (Loss) | (48,567) | (141,187) | (22,586) | (27,207) | (29,494) | (4,912) | (5,324) | (4,518) |
| Earnings Per Share (Basic) | (0.82) | (2.40) | (0.38) | (0.46) | (0.50) | (0.08) | (0.09) | (0.08) |
| Earnings Per Share (Diluted) | (0.82) | (2.40) | (0.38) | (0.46) | (0.50) | (0.08) | (0.09) | (0.08) |
| Weighted Average Shares Outstanding (Basic) | 59,460 | 58,930 | 59,091 | 58,994 | 58,528 | 58,149 | 58,262 | 58,221 |
| Weighted Average Shares Outstanding (Diluted) | 59,460 | 58,930 | 59,091 | 58,994 | 58,528 | 58,149 | 58,262 | 58,221 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About VNDA
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is a stock listed on the Nasdaq Stock Market under the ticker symbol VNDA. It last traded at $3.44 (Nov 20, 2026, 4:00 PM ET), down 6.1% on the day. That gives Vanda Pharmaceuticals a market capitalisation of $226.4M.
Over the past 52 weeks VNDA has traded between $3.56 and $9.94.
Revenue for the quarter ended Mar 31, 2026 was $51.7M; a net loss of $48.6M. Revenue was up 3.4% from $50.0M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $51.7M | -$48.6M | -93.9% |
| Dec 31, 2025 | $57.2M | -$141.2M | -246.8% |
| Sep 30, 2025 | $56.3M | -$22.6M | -40.1% |
| Jun 30, 2025 | $52.6M | -$27.2M | -51.7% |
From Vanda Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…